StocksBiogen IncBIIB

BIIB

Biogen Inc

197.78 -2.84 (-1.42%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
197.41
B
198.07

Overview

Prev Close197.78
Day's Range 194.10 - 199.73
52 Week Range 186.98 - 290.47
Average Volume (3m)938.11K
1-Year Return-32.22%
Beta0.7735
Market Cap28.7B
P/E Ratio14.12
Revenue10.01B
EPS14.0065
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Chart times in UTC
Industry Biotechnology
CEO Michel Vounatsos, MBA
Employees 9,610

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Biogen Inc's revenues decreased by 11.12% and amounted to 10.98B. Net income decreased by 57.45% to 1.73B. Net assets increased by 2.56% to 10.96B and EPS decreased from 24.80 to 10.40.
BIIB's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
70.55%
Net Profit Margin
30.70%
Operating Margin
22.03%
Return On Investment
19.97%
09/21
12/21
03/22
06/22
Total Revenue
2.78B
2.73B
2.53B
2.59B
Gross Profit
2.27B
2.07B
1.78B
2.11B
Operating Income
851.2M
525.8M
524.4M
936.4M
Net Income
318.1M
-20.5M
218.5M
1.06B